(NASDAQ: LNTH) Lantheus Holdings's forecast annual revenue growth rate of 7.14% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.98%.
Lantheus Holdings's revenue in 2026 is $1,546,178,000.On average, 15 Wall Street analysts forecast LNTH's revenue for 2026 to be $97,333,592,590, with the lowest LNTH revenue forecast at $90,953,196,554, and the highest LNTH revenue forecast at $108,206,308,284. On average, 15 Wall Street analysts forecast LNTH's revenue for 2027 to be $109,573,536,006, with the lowest LNTH revenue forecast at $99,872,729,788, and the highest LNTH revenue forecast at $127,021,965,982.
In 2028, LNTH is forecast to generate $124,287,510,538 in revenue, with the lowest revenue forecast at $108,922,475,186 and the highest revenue forecast at $143,298,486,482.